Results 41 to 50 of about 29,347 (276)

Vulvar cancer in Iran: Retrospective study over 20 years (1998-2018)

open access: yesJournal of Family Medicine and Primary Care, 2019
Background: We did not have any data about vulvar cancer — as a fourth cause of gynecological cancer in the worldwide — in our country. Study Design: Our study is designed to evaluate the frequency, stage and outcome of patients with vulvar cancer ...
Azamosadat Mousavi   +4 more
doaj   +1 more source

Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994 [PDF]

open access: yes, 2017
Background: To analyse trends in incidence, survival and risk of second neoplasms following vaginal and vulvar cancers using data collected by the Swiss Cancer Registry of Vaud over the 21-year period 1974-1994.
La Vecchia, C.   +2 more
core  

The role of Rho GTPases in facial morphogenesis

open access: yesDevelopmental Dynamics, EarlyView.
The role of small GTPases, RHOA, RAC1, and CDC42 and pathway mediators is reviewed in the context of embryonic facial development. Lip fusion requires cytoskeletal remodeling during morphogenesis of the facial processes and during lip fusion. Fnm, frontonasal mass; lnp, lateral nasal process; mnp, medial nasal process; mxp, maxillary process; np, nasal
Isra Ibrahim, Joy M. Richman
wiley   +1 more source

HPV vaccination of immunocompromised hosts. [PDF]

open access: yes, 2017
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly ...
Bhatla, N   +9 more
core   +3 more sources

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar   +14 more
wiley   +1 more source

High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC) [PDF]

open access: yes, 2001
Vulval intraepithelial neoplasia (VIN) is thought to be the premalignant phase of human papillomavirus (HPV)-associated vulval squamous cell carcinoma (VSCC).
Abbou, M. (Mustaffa)   +6 more
core   +6 more sources

CACA guidelines for vulvar malignancies

open access: yesHolistic Integrative Oncology
Objective The purpose of this study is to provide reference and guidance for the clinical diagnosis and treatment of vulvar malignancies. Method This article sorts out and integrates the contents of vulvar malignancies in the field of traditional Chinese
Zhongqiu Lin   +9 more
doaj   +1 more source

Subcutaneous Vulvar Flap Viability Evaluation With Near-Infrared Probe and Indocyanine Green for Vulvar Cancer Reconstructive Surgery: A Feasible Technique

open access: yesFrontiers in Surgery, 2021
Introduction: Vulvar cancer is a rare condition affecting older women and accounts for 3–5% of all gynecological cancers. Primary surgical treatment involves the removal of a large amount of tissue for which reconstructive surgery is often necessary with
Vito Andrea Capozzi   +9 more
doaj   +1 more source

Morbidity following Surgical Management of Vulval Cancer. [PDF]

open access: yes, 2012
The objective of this study was to know the complications following vulvectomy and inguinofemoral lymphadenectomy including the time taken to complete wound healing.
Bafna, UD   +4 more
core  

Interstitial brachytherapy with 192Ir in vulvar cancer [PDF]

open access: yes, 2006
Vulvar cancer accounts for 5% of all female genital cancers and 1% of all malignancies in women. A female patient, 78 years old, with diagnosed squamous cell carcinoma of vulva stage II, was admitted to our Institution in January 2004. An exophytic tumor,
Baucal Milutin   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy